These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 30090091)
1. Immunomodulation as Therapy for Fungal Infection: Are We Closer? Sam QH; Yew WS; Seneviratne CJ; Chang MW; Chai LYA Front Microbiol; 2018; 9():1612. PubMed ID: 30090091 [TBL] [Abstract][Full Text] [Related]
2. Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy. Roilides E; Lamaignere CG; Farmaki E Int J Infect Dis; 2002 Sep; 6(3):154-63. PubMed ID: 12718828 [TBL] [Abstract][Full Text] [Related]
3. Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults. Corvilain E; Casanova JL; Puel A J Clin Immunol; 2018 Aug; 38(6):656-693. PubMed ID: 30136218 [TBL] [Abstract][Full Text] [Related]
4. Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges. Giannella M; Lanternier F; Dellière S; Groll AH; Mueller NJ; Alastruey-Izquierdo A; Slavin MA; Clin Microbiol Infect; 2024 Aug; ():. PubMed ID: 39142631 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation Therapy for Invasive Aspergillosis: Discussion on Myeloid Growth Factors, Recombinant Cytokines, and Antifungal Drug Immune Modulation. Safdar A Curr Fungal Infect Rep; 2010 Mar; 4(1):1-7. PubMed ID: 23585915 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges. Ademe M Front Cell Infect Microbiol; 2020; 10():469. PubMed ID: 33042859 [TBL] [Abstract][Full Text] [Related]
7. Defective antifungal immunity in patients with COVID-19. Morton CO; Griffiths JS; Loeffler J; Orr S; White PL Front Immunol; 2022; 13():1080822. PubMed ID: 36531987 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of Fungal Infections. Datta K; Hamad M Immunol Invest; 2015; 44(8):738-76. PubMed ID: 26575463 [TBL] [Abstract][Full Text] [Related]
9. Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial. Wan L; Zhang Y; Lai Y; Jiang M; Song Y; Zhou J; Zhang Z; Duan X; Fu Y; Liao L; Wang C J Clin Oncol; 2015 Dec; 33(34):3999-4006. PubMed ID: 26392095 [TBL] [Abstract][Full Text] [Related]
10. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Kumaresan PR; Wurster S; Bavisi K; da Silva TA; Hauser P; Kinnitt J; Albert ND; Bharadwaj U; Neelapu S; Kontoyiannis DP mBio; 2024 Apr; 15(4):e0341323. PubMed ID: 38415653 [TBL] [Abstract][Full Text] [Related]
12. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole. Thompson GR; Chen SC; Alfouzan WA; Izumikawa K; Colombo AL; Maertens J Med Mycol; 2024 Sep; 62(9):. PubMed ID: 39138063 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia. White PL; Price JS; Posso RB; Barnes RA Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117 [TBL] [Abstract][Full Text] [Related]
14. Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma. Little JS; Aleissa MM; Beluch K; Gonzalez-Bocco IH; Marty FM; Manne-Goehler J; Koo S; Hammond SP; Jacobson CA Blood Adv; 2022 Aug; 6(16):4821-4830. PubMed ID: 35802461 [TBL] [Abstract][Full Text] [Related]
16. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease. Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center. Lum L; Lee A; Vu M; Strasser S; Davis R Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755 [TBL] [Abstract][Full Text] [Related]
18. Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study. Lim C; Sinha P; Harrison SJ; Quach H; Slavin MA; Teh BW Mycoses; 2021 Jan; 64(1):30-34. PubMed ID: 32885525 [TBL] [Abstract][Full Text] [Related]
19. Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation. Ceesay MM; Kordasti S; Rufaie E; Lea N; Smith M; Wade J; Douiri A; Mufti GJ; Pagliuca A J Infect; 2016 Sep; 73(3):280-8. PubMed ID: 27343564 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]